On-Demand Upstream Manufacturing Webinars

  1. Achieving Clinical Quality For Human iPSC Generation And Expansion 6/11/2026

    Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.

  2. Automated GMP-Compliant PSC Banking In A Closed System 6/11/2026

    Explore advances in automated adherent cell culture and the optimization of large-scale iPSC expansion, as well as how standardization and process control are improving reproducibility.

  3. Manufacturing GMP-Compliant iPSCs In Closed And Open Systems 6/11/2026

    Gain practical insight into scaling human iPSC manufacturing with expert perspectives on process control, reproducibility, and automated workflows designed to support stem cell expansion.

  4. Advancing Clinical-Grade TIL Therapy Manufacturing 6/11/2026

    TIL therapy continues to advance, but manufacturing complexity limits its potential. See how automated workflows for generating tumor-reactive T cells can improve consistency, scalability, and readiness.

  5. Automated And Streamlined Manufacturing Of TIL Therapies 6/11/2026

    Advances in TIL therapy are driving a shift from manual processes to streamlined, automated manufacturing. Discover how improved workflows and early clinical results are shaping cancer treatments.

  6. Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis 5/6/2026

    Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.

  7. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

    See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

  8. Industrializing Cell Therapy With Perfusion 4/14/2026

    Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.

  9. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

    Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

  10. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.